XML 63 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments and Fair Value Measurements (Schedule of Reconciliation of Changes in Fair Value of Contingent Liabilities) (Details) - USD ($)
$ in Millions
9 Months Ended
Sep. 25, 2020
Dec. 27, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Contingent Consideration, Liability, Current $ 13.2  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent Consideration, Liability, Noncurrent 14.0  
Level 3 | Recurring | Contingent Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance 69.3  
Accretion expense 0.5  
Fair value adjustment 2.4  
Ending balance 27.2  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements (45.0)  
Questcor Pharmaceuticals, Inc. | Level 3 | Recurring    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value of contingent liability 0.0 $ 24.5
StrataGraft [Member] | Stratatech | Level 3 | Recurring    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value of contingent liability 15.8 29.0
MNK-6105 [Member] | Ocera [Member] | Level 3 | Recurring    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent Consideration, Liability $ 11.4 $ 15.8